CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 119 filers reported holding CHEMOCENTRYX INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,576,000 | +49.1% | 185,467 | +17.1% | 0.06% | +24.4% |
| Q4 2018 | $1,728,000 | +3.2% | 158,370 | +19.6% | 0.04% | +28.6% |
| Q3 2018 | $1,674,000 | -57.2% | 132,364 | -54.1% | 0.04% | -53.3% |
| Q2 2018 | $3,907,000 | +45.8% | 288,300 | +46.3% | 0.08% | +31.6% |
| Q1 2018 | $2,679,000 | +104.3% | 197,014 | -11.2% | 0.06% | +103.6% |
| Q4 2017 | $1,311,000 | -29.2% | 221,792 | -10.0% | 0.03% | -22.2% |
| Q3 2017 | $1,853,000 | +10.3% | 246,369 | +37.3% | 0.04% | +9.1% |
| Q2 2017 | $1,680,000 | +7.0% | 179,459 | -16.8% | 0.03% | -13.2% |
| Q1 2017 | $1,570,000 | -24.3% | 215,681 | -23.0% | 0.04% | -48.6% |
| Q4 2016 | $2,073,000 | +4.9% | 280,147 | -14.4% | 0.07% | +21.3% |
| Q3 2016 | $1,977,000 | -17.9% | 327,389 | -39.0% | 0.06% | -22.8% |
| Q2 2016 | $2,409,000 | – | 536,521 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |